Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
Cytotherapy. 2019 Aug;21(8):856-869. doi: 10.1016/j.jcyt.2019.02.005. Epub 2019 Jun 11.
Acute or chronic injury of articular cartilage leads to localized destruction. Difficulties with interface integration between the implant and native cartilage tissue can lead to an undesirable outcome. To improve cartilage repair and interface integration, we explored the therapeutic efficacy of microporous acellular extracellular matrix (ECM) combined with adipose-derived stem cell (ASC) sheets.
Methods for fabricating ASC sheets and microporous acellular ECM were explored before transplanting the constructed ASC sheet/matrix in vivo and in vitro, respectively. After the operation, distal femur samples were collected at 6 and 12 weeks for further analysis.
The decellularization process removed 90% of the DNA but retained 82.4% of glycosaminoglycans (GAGs) and 82.8% of collagen, which are the primary components of cartilage matrix. The acellular matrix/ASC sheet construct treatment in vivo showed better interface integration, cartilage regeneration, and collagenous fiber arrangement, which resembles the native structure. There was a significant increase in GAG and collagen accumulation at the zone of regeneration and integration compared to other groups. Gene expression analysis showed that the mRNA level associated with cartilage formation significantly increased in the acellular matrix/ASC sheet group (p<0.05), which is consistent with the histological analysis.
ASC sheets promote interface integration between the implant and native tissue. This effect, together with the acellular matrix as a graft, is beneficial for cartilage defect repair, which suggests that acellular matrix/ASC sheet bioengineered cartilage implants may be a better approach for cartilage repair due to their enhanced integration.
关节软骨的急性或慢性损伤会导致局部破坏。植入物与天然软骨组织之间界面整合的困难可能导致不理想的结果。为了改善软骨修复和界面整合,我们探索了微孔去细胞细胞外基质(ECM)与脂肪来源干细胞(ASC)片结合的治疗效果。
在体内和体外分别移植构建的 ASC 片/基质之前,探索了 ASC 片和微孔去细胞 ECM 的制造方法。手术后,在 6 周和 12 周时收集远端股骨样本进行进一步分析。
脱细胞过程去除了 90%的 DNA,但保留了 82.4%的糖胺聚糖(GAG)和 82.8%的胶原蛋白,它们是软骨基质的主要成分。体内的无细胞基质/ASC 片构建物治疗显示出更好的界面整合、软骨再生和胶原纤维排列,类似于天然结构。与其他组相比,在再生和整合区有明显增加的 GAG 和胶原积累。基因表达分析显示,无细胞基质/ASC 片组中与软骨形成相关的 mRNA 水平显著增加(p<0.05),这与组织学分析一致。
ASC 片促进了植入物与天然组织之间的界面整合。这种效果,加上作为移植物的无细胞基质,有利于软骨缺陷修复,这表明由于增强的整合,无细胞基质/ASC 片生物工程软骨植入物可能是更好的软骨修复方法。